CYSLTR2 and neoplasm: This finding was supported by the data generated from our earlier publications at the protein level using the patient CRC tumor microarray (TMA), which showed that high protein expression of CysLT1R was associated with poor prognosis and that low protein expression of CysLT2R was positively correlated with poor prognosis in CRC patients [14].